US Pre-Market SEC Filings Roundup — October 29, 2026

28-10-2026

Auto Services Company, Inc. (ASC), together with ASC Holding Company and controlling holder Bradley L. Hasselwander, filed Amendment No. 3 to Schedule 13D disclosing a privately negotiated sale of 300,000 shares of Bassett Furniture Industries (BSET) common stock back to the issuer under a Share Repurchase Agreement dated October 26, 2026, at $22.0473 per share (a 1% discount to the $22.27 Nasdaq closing price), for an aggregate price of $6,614,190. Following the repurchase, the reporting persons would retain 756,317 shares, approximately 8.7% of outstanding common stock.

• · The repurchase is a privately negotiated transaction in which ASC is reducing its position; the reporting persons state they will hold the remaining shares for investment purposes and may buy or sell more in the future.
• · Representations and warranties under the Repurchase Agreement survive closing for twelve months.
• · The repurchase is contemplated and, as of filing, not yet consummated; the filing states the reporting persons have effected no other BSET transactions in the past 60 days.
• · The filing reports ownership on the basis of the Issuer's Q2 fiscal 2026 Form 10-Q (quarter ended August 29, 2026), filed September 30, 2026.
• · The Repurchase Agreement is filed as Exhibit 2 with certain personal information redacted under Item 601(a)(6) of Regulation S-K.

28-10-2026

FEPCF Founders Fund, L.P. and affiliated First Eagle entities filed Amendment No. 3 to Schedule 13D reporting beneficial ownership of 8,307,057 common shares of First Eagle Private Credit Fund, representing 64.7% of 12,848,278 shares outstanding as of October 23, 2026. The change is driven mainly by dividend reinvestment: First Eagle Investment Management (FEIM) acquired 1,202 shares at a weighted average price of $24.09 per share through the issuer's dividend reinvestment plan. No material change in control or intent is reported in the excerpted text.

• · This is Amendment No. 3; prior amendments were filed on October 11, 2023 and March 5, 2024, following the original 13D filed July 20, 2023
• · Founders Fund's 8,301,855 shares and FEIM's 5,202 shares are held directly; the reporting group states it may be deemed beneficial owner, with a disclaimer of admission of beneficial ownership
• · No transactions in Common Shares by reporting persons in the past 60 days apart from the disclosed dividend reinvestment, per the filing

28-10-2026

Director LEWIS JIM sold 183 Common Stock at $32.40 (~$5.93K). LEWIS JIM holds 153,308 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · Director LEWIS JIM was awarded 695 Common Stock
• · Director LEWIS JIM sold 183 Common Stock at $32.40 (~$5.93K)

28-10-2026

President and CEO Roks Edwin bought 5,000 Common Stock at $88.07 (~$440K). Roks Edwin holds 64,483 shares after the transaction.

• · President and CEO Roks Edwin bought 5,000 Common Stock at $88.07 (~$440K)

28-10-2026

Chief People & AI Enblmt. Off. Canney Jacqueline P was awarded 79,078 Restricted Stock Units.

• · Chief People & AI Enblmt. Off. Canney Jacqueline P was awarded 79,078 Restricted Stock Units

28-10-2026

Director Nonko Eugene sold 8,283 Class A Common Stock at $11.85 (~$98.1K). 6 transactions reported in total. Nonko Eugene holds 789,901 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · Director Nonko Eugene sold 1,940 Class A Common Stock at $11.83 (~$22.9K)
• · Director Nonko Eugene sold 3,394 Class A Common Stock at $11.92 (~$40.5K)
• · Director Nonko Eugene sold 1,940 Class A Common Stock at $11.63 (~$22.6K)
• · Director Nonko Eugene sold 7,273 Class A Common Stock at $11.83 (~$86K)
• · Director Nonko Eugene sold 8,283 Class A Common Stock at $11.85 (~$98.1K)
• · Director Nonko Eugene sold 7,273 Class A Common Stock at $11.63 (~$84.6K)

28-10-2026

Director Scanlon George P disposed to the issuer 153,681 Common Stock.

• · Director Scanlon George P disposed to the issuer 153,681 Common Stock

28-10-2026

See Remarks Ogle Trevor sold 2,093 Common Stock at $95.81 (~$201K). Trades executed under a Rule 10b5-1 plan.

• · See Remarks Ogle Trevor sold 2,093 Common Stock at $95.81 (~$201K)

28-10-2026

Uppal Manpreet was awarded 20,000 Common Stock. Uppal Manpreet holds 60,000 shares after the transaction.

• · Uppal Manpreet was awarded 20,000 Common Stock

29-10-2026

Alphabet reported Q3 2026 (three months ended September 30, 2026) revenues of $127,577 million, up 24.6% YoY from $102,346 million, and net income of $26,468 million, down 24.3% YoY from $34,979 million, as other income swung from a $12,759 million gain to an $8,221 million expense. Operating income grew 29.9% YoY to $40,576 million, while diluted EPS fell to $2.12 from $2.87, and expenses rose across R&D and cost of revenues even as general and administrative costs declined.

• · Other income swung from a $12,759 million gain in Q3 2025 to an $8,221 million expense in Q3 2026, the main driver of the net income decline despite stronger operating income.
• · Q3 2026 research and development expense rose 36.2% YoY to $20,640 million, while cost of revenues rose 24.4% and sales and marketing rose 22.2%.
• · Q3 2026 general and administrative expense fell 17.0% YoY to $6,138 million.
• · Nine-month 2026 net income includes a $127,478 million other income contribution versus $26,604 million in the prior-year period.
• · Long-term debt rose from $46,547 million to $125,102 million between December 31, 2025 and September 30, 2026.
• · Total cash, cash equivalents, and marketable securities rose to $265,098 million from $126,843 million at year-end 2025.
• · Q3 2026 other comprehensive loss of $(2,041) million compared with a gain of $73 million in Q3 2025, reducing comprehensive income to $24,427 million.

29-10-2026

Ford Motor Company's Form 10-Q for the quarter ended September 30, 2026 shows total revenues of $49,526 Million in Q3 2026, down from $50,534 Million in Q3 2025 (-2.0%), and $141,075 Million for the first nine months of 2026 versus $141,377 Million a year earlier (-0.2%). Net income attributable to Ford was $2,049 Million in Q3 2026, down from $2,447 Million (-16.3%), though first-nine-month net income rose to $3,270 Million from $2,882 Million (+13.5%), helped by a non-cash charge in the current period. Total assets grew to $292,484 Million from $289,160 Million at year-end 2025, while cash and marketable securities declined.

• · Q3 2026 vehicle, parts, and accessories revenue fell to $44,178 Million from $45,492 Million (-2.9%), while used vehicle revenue rose to $843 Million from $687 Million (+22.7%)
• · Company excluding Ford Credit net revenue fell 5.2% in Q3 on lower leasing income ($66 Million vs. $104 Million), while Ford Credit leasing income rose to $1,388 Million from $1,245 Million
• · Ford Credit financing income declined to $1,993 Million in Q3 2026 from $2,040 Million, and first-nine-month financing income fell to $5,990 Million from $6,094 Million
• · First-nine-month 2026 net income includes a $2,930 Million non-cash charge for the disposition of the BOSK investment, which weighed on operating cash flow reconciliation
• · Capital spending rose to $7,043 Million in the first nine months of 2026 from $6,031 Million, while dividend payments fell to $1,804 Million from $2,390 Million
• · Net changes in short-term debt were a $1,197 Million outflow in the first nine months of 2026 versus a $406 Million outflow a year earlier; Ford also repurchased $311 Million of common stock
• · Non-Ford Credit debt payable within one year fell to $4,154 Million from $5,550 Million, while long-term debt excluding Ford Credit rose to $19,535 Million from $16,369 Million
• · Q3 2026 net income was $2,049 Million versus $2,447 Million in Q3 2025, with Q3 2026 results including quarterly pension/OPEB income of $357 Million versus $19 Million a year earlier

29-10-2026

KB Financial Group Inc. filed a Form 6-K on October 29, 2026 designating November 12, 2026 as the record date for its third-quarter 2026 interim cash dividends, pursuant to Article 60 of its Articles of Incorporation. Shareholders of record on that date will receive the dividend, with no closing of the shareholder registry. The filing is a routine administrative disclosure with no dividend amount stated.

• · Record date for Q3 2026 interim cash dividend: November 12, 2026
• · No closing of the shareholder registry; entitlement is determined solely by the record date
• · Dividend authority under Article 60: Board resolution within 45 days after the end of March, June, or September
• · The Company must give at least two weeks' public notice of the record date

29-10-2026

HUTCHMED (China) Limited furnished a Form 6-K under which it attached a press release announcing that the US FDA granted orphan drug designation to sovleplenib for the treatment of primary immune thrombocytopenia (ITP). The filing is a regulatory-development disclosure with no financial figures, guidance, or quantitative results included.

• · The designation applies to primary immune thrombocytopenia, a rare autoimmune blood disorder.
• · The announcement is furnished as Exhibit 99.1 to the Form 6-K dated October 29, 2026.
• · HUTCHMED reports under Form 20-F, as indicated on the cover page.

29-10-2026

ASE Technology Holding reported Q3 2026 net revenues of NT$244,161 million, up 28% QoQ and 45% YoY, with operating income of NT$33,142 million (+57% QoQ, +151% YoY) and net income attributable to shareholders of NT$26,996 million (+28% QoQ, +148% YoY). Growth was driven by ATM revenue (+52% YoY) and EMS revenue (+36% YoY), while Others revenue declined 26% YoY and 2% QoQ. Net debt to equity rose to 0.66 from 0.47 in Q2 2026, and total interest-bearing debt increased to NT$406,461 million from NT$306,230 million.

• · EMS revenue growth of 42% QoQ and 36% YoY was offset by EMS operating margin compression to 3.3% from 3.7% YoY while EMS gross margin fell to 8.3% from 9.2% YoY.
• · Non-controlling interests rose to NT$883 million from NT$491 million YoY and NT$460 million QoQ.
• · Current ratio improved to 1.16 from 1.07 QoQ, while Q2 2026 included a non-operating gain of NT$4,566 million that did not recur in Q3 2026, which posted a non-operating loss of NT$432 million.
• · Property, plant and equipment increased to NT$621,962 million from NT$517,715 million QoQ, and total liabilities rose to NT$790,863 million from NT$652,248 million.
• · Quarterly PPA expenses were roughly NT$781 million in Q3 2026 (including ASE/SPIL-related and USI-related amounts), excluded from the non-GAAP-style 'excl. PPA' figures.
• · Q4 2026 guidance projects consolidated gross margin of 23-24% and operating margin of 14.5-15.5%, implying modest margin change from Q3 2026 levels (22.1% and 13.6%).

29-10-2026

Trump Media & Technology Group (DJT) filed Amendment No. 1 to its Form S-4 registration statement for an all-stock merger with TAE Technologies, Inc., under a Merger Agreement dated December 18, 2025. TMTG shareholders will vote at a virtual special meeting on December 14, 2026 on increasing authorized common stock from 999,000,000 to 1,998,000,000 and preferred stock from 1,000,000 to 2,000,000, and on a share issuance exceeding 20% of pre-merger outstanding shares; the merger cannot close without approval of both proposals. Pre-merger TMTG holders would own approximately 53.8% of the Combined Company (49.5% fully diluted), versus 45.1% for TAE holders (49.5% fully diluted). The DJT stock price declined from $10.47 (December 17, 2025) to $6.14 (October 26, 2026), a decline of approximately 41.4%.

• · The Donald J. Trump Revocable Trust has entered a Voting and Support Agreement to vote all its TMTG shares in favor of the proposals and generally not transfer them.
• · Certain TAE stockholders entered Voting and Support Agreements to approve the Merger Agreement, Conversion and related transactions.
• · The Merger and Conversion are expected to qualify as tax-free reorganizations under Section 368(a) of the Code, with cash received in lieu of fractional shares being taxable.
• · Failure to vote on the Articles Amendment Proposal has the same effect as a vote against it.
• · Merger consummation requires approval of both the Articles Amendment and Share Issuance proposals; the Adjournment Proposal is a fallback if votes are insufficient.
• · The filing is preliminary and subject to completion; proxy materials are expected to be first mailed to shareholders on or about November 6, 2026.
• · Risk Factors are presented beginning on page 29 of the proxy statement/prospectus.

29-10-2026

Resolution Minerals Ltd (ASX-listed) reported a quarterly cash flow report showing net cash used in operating activities of A$2,382 thousand and net cash used in investing activities of A$6,341 thousand, primarily for exploration and evaluation, with financing inflows of only A$17 thousand. Cash and cash equivalents fell from A$10,343 thousand to A$1,637 thousand, implying roughly 0.2 quarters of funding on the entity's own estimate, although the company states it has access to funding and no change to near-term funding requirements. The company says the drilling program has been completed and exploration spend is expected to decline next quarter.

• · Estimated quarters of funding available is 0.2 (item 8.7), below the 2-quarter threshold that triggers additional disclosure requirements under ASX rules
• · Company states unused finance facilities available at quarter end are nil (item 8.5), so available funding equals cash on hand only
• · Interest received of A$57 thousand was the only reported investment income line item
• · No equity raise proceeds were recorded this quarter; financing inflows were limited to option exercises of A$43 thousand offset by A$214 thousand of transaction costs
• · Previous quarter's cash balance of A$10,343 thousand was reported in the consolidated statement of cash flows

29-10-2026

Proto Labs reported record third-quarter 2026 revenue of $154.3 million, up 14.0% YoY, with GAAP diluted EPS of $0.48 (up from $0.30) and non-GAAP diluted EPS of $0.63 (up from $0.47). Full-year 2026 revenue growth guidance was raised to 10%-11% from 8%-10%, while Q4 2026 revenue guidance of $143.0M-$151.0M and GAAP EPS of $0.28-$0.36 implies a sequential slowdown from Q3 levels. Cash and investments stood at $175.0 million, though nine-month operating cash flow declined modestly and share repurchases fell sharply year over year.

• · Q4 2026 GAAP diluted EPS guidance of $0.28-$0.36 and non-GAAP EPS guidance of $0.46-$0.54 imply a meaningful sequential decline from Q3 results
• · Sheet Metal revenue declined about 4.7% YoY in Q3 2026, the only product line that contracted
• · Nine-month operating cash flow fell about 3.7% YoY to $55.7M, despite higher earnings, due to a $14.6M unfavorable working capital change
• · Nine-month share repurchases were $10.0M versus $36.7M a year earlier, a roughly 73% reduction
• · Accounts receivable rose to $99.3M from $79.0M at year-end 2025, a 26% increase
• · Q3 2026 Adjusted EBITDA margin was 17.0% versus 15.6% in Q3 2025; GAAP operating margin of 9.4% remains below the non-GAAP figure of 11.9%
• · Q3 2026 non-GAAP net income was $15.3M versus $11.4M in the prior year period

29-10-2026

AMBEV S.A. (ABEV) reported 3Q26 results with net revenue up 7.6% to R$21,594.6 million and normalized EBITDA up 8.9% to R$7,270.9 million on an organic basis, with normalized EBITDA margin at 33.7% of net revenue. However, reported EBITDA declined 3.0% to R$7,250.7 million, net finance results worsened from a R$1,086.0 million expense in 3Q25 to a R$312.4 million expense in 3Q26 (an improvement, but still negative), and Canada's EBITDA fell 37.2% to R$1,221.8 million while Brazil's EBITDA rose 1.1%.

• · Canada EBITDA declined 42.1% YoY in 3Q26 on a reported basis, while its normalized EBITDA rose 11.4% on the organic-results table, reflecting a large prior-year exceptional item of R$883.0 million
• · Interest expenses rose to R$560.3 million in 3Q26 from R$488.0 million in 3Q25, while exchange differences swung to a R$151.7 million gain from a R$524.1 million loss
• · Interest on provisions for disputes and litigation fell to R$71.9 million from R$204.7 million year over year
• · Consolidated volume was roughly flat in 3Q26 at 42,385.0 thousand hl (-0.1%), with Brazil volume up 0.5% and CAC volume up 3.6%, while LAS volume declined 1.4%
• · Total assets decreased to R$141,574.7 million at September 30, 2026 from R$145,087.2 million at December 31, 2025, and total liabilities declined to R$50,132.8 million from R$56,312.4 million
• · Retained earnings were R$11,192.3 million at September 30, 2026 versus nil at December 31, 2025

29-10-2026

Chilwa Minerals Ltd's quarterly cash flow report (6-K) shows net cash used in operating activities of A$381 thousand, investing outflows of A$559 thousand (including A$521 thousand of exploration & evaluation spending), and financing outflows of A$156 thousand after A$188 thousand of equity transaction costs. Cash and cash equivalents fell from A$1,102 thousand to A$5 thousand over the period. Management states that funding covers only about 1.67 quarters of outgoings including an undrawn A$1,500 thousand facility, and that operating outflows will rise in the December quarter as creditors deferred from September are settled after the Nasdaq IPO proceeds were received on 5 October 2026.

• · Estimated funding runway is 1.67 quarters, below the 2-quarter threshold that triggers additional disclosure questions under ASX reporting requirements.
• · Bank overdrafts of A$37 thousand were recorded at quarter end, with no overdrafts in the previous quarter.
• · Receipts from customers were only A$28 thousand, with interest received of A$3 thousand and no production revenue.
• · Management expects operating outflows in the December quarter to be higher than in September as deferred creditor payments are settled.
• · Exploration expenditure is discretionary and is being managed in line with available funding.

29-10-2026

Cohu reported Q3 2026 (three months ended September 26, 2026) net sales of $172,956K, up 37.0% YoY from $126,249K, and net income of $12,129K versus a net loss of $(4,101)K a year earlier, with operating income of $12,801K compared to an operating loss of $(9,716)K. However, nine-month results remained near breakeven, with net loss of $(98)K (vs. $(51,785)K) and operating income of only $1,939K, and gross margin on a cost-of-sales basis compressed as cost of sales rose faster than revenue on a nine-month basis (cost of sales +30.6% vs. net sales +35.2% in the same comparison, while inventories and receivables grew substantially).

• · Nine-month 2026 cash used in investing included $206,678K in sales/maturities of short-term investments offset by $183,960K in purchases, and capex fell to $6,961K from $17,583K.
• · Long-term debt of $285,212K and short-term borrowings of $15,636K at September 26, 2026, with nine-month interest expense rising to $5,054K from $434K.
• · Nine-month restructuring charges declined to $1,839K from $8,347K, and amortization of purchased intangibles fell to $21,754K from $30,182K.
• · Accumulated other comprehensive loss widened to $(40,691)K from $(32,470)K at year-end 2025, driven by a $(7,128)K cumulative translation adjustment.
• · Q3 2026 diluted EPS of $0.22 compares with basic EPS of $0.26, reflecting dilution to 54,366K diluted shares.
• · Nine-month 2026 foreign transaction losses of $(1,150)K widened from $(551)K a year earlier.

29-10-2026

Sumitomo Mitsui Trust Group, Inc. filed a Form 13F-HR for the quarter ended September 30, 2026, disclosing its U.S. Section 13(f) equity holdings as a combination report covering several affiliated managers, including Amova Asset Management Americas, Inc., Sumitomo Mitsui Trust Bank Ltd., Amova Asset Management Co., Ltd., Sumitomo Mitsui Trust Asset Management Co., Ltd., Amova Asset Management UK Ltd, Amova Asset Management Asia Ltd, and AHAM Asset Management Berhad. The information table lists a large number of long equity positions, with the largest reported values including Amazon.com, Broadcom, Apple, Bank of America, Berkshire Hathaway Class B, and Advanced Micro Devices. The filing is a routine quarterly disclosure and does not by itself indicate a material corporate event, though the filing's aggregate reported value of 174,374,003,787 (in dollars, as reported in the cover page's table value total) is a notable scale of U.S. equity exposure.

• · Filing covers the quarter ended September 30, 2026 and was filed October 29, 2026 (accession 0001214659-26-013361).
• · Filer is a combination report (13F COMBINATION REPORT) with six other included managers, reported under SEC file number 028-14527.
• · Largest reported position values include Amazon.com (~$6.05B) and Broadcom (~$3.87B), with Apple also among the top holdings by share count (32,337,169 shares).

29-10-2026

Sumitomo Mitsui Trust Group, Inc. and its subsidiary Amova Asset Management Co., Ltd. filed an amended Schedule 13G reporting beneficial ownership of 1,689,107 shares of Arcturus Therapeutics Holdings Inc. common stock, representing 5.9% of the class, with sole voting and dispositive power held through Amova Asset Management Americas, Inc. The filing is a passive institutional disclosure under Rule 13d-1(b) with no stated intent to influence control of the issuer.

• · The filing is an amendment (SCHEDULE 13G/A) citing a prior statement, with the reported event date of 09/30/2026 and filing date of 10/29/2026
• · Voting and dispositive power is reported as zero sole and 1,689,107 shared for both reporting persons
• · The filing is made under Rule 13d-1(b) as a parent holding company, non-U.S. institution, and group, and includes a certification that the shares are held in the ordinary course of business without intent to influence control

29-10-2026

Sumitomo Mitsui Trust Group, Inc. filed an amended Schedule 13G reporting beneficial ownership of 121,591,698 shares of Mizuho Financial Group common stock as of September 30, 2026, equal to 5.0% of the class. The filing reflects holdings through its asset management subsidiaries, with 114,648,798 shares reported as having shared voting power and no sole voting or dispositive power reported as a discrete figure. The filing is a routine passive beneficial ownership disclosure made under Rule 13d-1(b) and does not indicate a change of control intent.

• · Nikko Asset Management Co., Ltd. changed its name to Amova Asset Management Co., Ltd. effective September 1, 2025.
• · Filing is made under Rule 13d-1(b) as a parent holding company and certifies the shares were acquired and held in the ordinary course of business without intent to influence control.
• · Reporting person identifies itself as a non-U.S. institution and investment adviser for certain subsidiaries.

29-10-2026

CICC and its affiliated reporting persons filed an amended Schedule 13G (Amendment) disclosing that they no longer beneficially own any Class A ordinary shares of uCloudlink Group Inc. (UCL), with 0 shares reported across all cover-page rows, reflecting a full exit from their prior holding. The filing is a routine ownership disclosure with no reported acquisition, sale amount, or price, and the filing does not state the size of the position that was disposed of.

• · Event date reported as 08/17/2026, which precedes the October 29, 2026 filing date, indicating the exit occurred roughly ten weeks before the disclosure
• · Filing is made under Rule 13d-1(c), a passive-investor certification, and the filer certifies the shares were not acquired to influence control of the issuer
• · Filing has a 'LIVE' amendment designation and references a prior Schedule 13G (accession 0000950103-24-005752), indicating an earlier 2024 position was held before this final exit
• · Filing includes a Joint Filing Agreement (Exhibit 99.1) among the four reporting persons under Rule 13d-1(k)(1)
• · Principal business address of CICC parent is in Beijing, PRC; subsidiaries and holding entities are based in Hong Kong

29-10-2026

Magnum Ice Cream Co reported Q3 2026 revenue of €2.511 billion, up 12.1% reported (9.6% organic sales growth) versus €2.240 billion in Q3 2025, with organic volume growth of 7.3% and organic price growth of 2.2%. Growth was broad but uneven: Europe & ANZ grew 12.6% reported (8.9% organic) and AMEA grew 17.3% reported (17.6% organic), while Americas grew 6.9% reported but only 3.9% organically, and Americas Q3 2025 had declined 6.6% reported. Reported growth was supported by a 2.6% contribution from acquisitions, partly offset by currency headwinds of 0.3%.

• · Europe & ANZ organic price growth turned negative at -2.4% in Q3 2026 after +2.5% a year earlier, with YTD price growth at -1.2%, indicating pricing pressure in the region's largest revenue base
• · Americas organic growth remained subdued: Q3 2026 organic sales +3.9% and YTD organic sales +3.4%, but Americas organic volume growth was only 1.7% in Q3 2026 and 0.6% YTD
• · Europe & ANZ organic volume growth of 11.6% in Q3 2026 was strong, but YTD organic volume growth of 7.1% reflects a recovery from weak prior-year comparisons (Q3 2025 -2.5%)
• · Group organic volume growth was flat to negative in Q3 2025 (-0.1%), so the 7.3% Q3 2026 volume recovery reflects a low base
• · Acquisitions contributed 2.6 percentage points to Q3 2026 reported growth (2.4 points YTD), meaning roughly one-fifth of reported growth was inorganic
• · Currency-related items were a 4.3-point drag in Q3 2025 but only a 0.3-point drag in Q3 2026, with exchange rate changes at -0.9 points versus -5.6 points a year earlier
• · Historical H2 2025 organic sales growth was negative in Europe & ANZ (-0.4%) and Americas (-0.3%); AMEA was the only region with strong H2 2025 growth (+11.1%)

29-10-2026

Escalade reported Q3 2026 net sales of $65.6 million, down 3.2% year-over-year, driven by lower basketball, indoor games and table tennis sales against tariff-timing-affected prior-year comparisons. Gross margin rose 123 basis points to 29.4%, net income increased to $6.7 million ($0.48 diluted EPS) from $5.6 million ($0.40), and EBITDA reached $10.0 million, including a $1.6 million tariff recovery benefit. Operating cash flow improved to $14.9 million from negative $1.0 million, while total debt fell to $13.1 million from $20.2 million a year earlier. Management flagged continued consumer headwinds from inflation, higher rates and geopolitical uncertainty.

• · Basketball, indoor games and table tennis categories declined, partially offset by archery (including Gold Tip), safety and outdoor games growth
• · Nine-month gross margin expanded more than 210 bps versus the prior-year period
• · Net cash position at quarter end with full revolver availability
• · Management expects consumer discretionary spending to remain under pressure through the holiday season
• · Quarterly dividend declared at $0.1525 per share, up from $0.1500 a year earlier

29-10-2026

Addex Therapeutics Ltd. furnished a Form 6-K on October 29, 2026, attaching a press release of the same date as Exhibit 99.1, which is incorporated by reference into its Form F-3 and Form S-8 registration statements. The filing body itself contains no financial figures, operational metrics, or period-over-period comparisons; the substantive content resides entirely in the unattached exhibit.

• · Filing reports a press release dated October 29, 2026 (Exhibit 99.1); the press release text is not included in the provided content
• · Registrant is a foreign private issuer filing Form 20-F (not Form 40-F), with Commission File Number 001-39179
• · Reference to Annual Report on Form 20-F for fiscal year ended December 31, 2025, filed May 15, 2026
• · Incorporated by reference into Form F-3 (Registration No. 333-291644) and Form S-8 (Registration Nos. 333-255124 and 333-272515)